1-naphthylamine has been researched along with Attention Deficit Disorder with Hyperactivity in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, JA; Goldman, R; Sarma, K; Tortorich, D; Tsai, J; Wigal, S; Zhu, H | 1 |
| Adler, LA; Goldman, R; Hopkins, SC; Hsu, J; Kent, J; Koblan, KS; Loebel, A | 1 |
| Adler, LA; Findling, RL; Goldman, R; Hopkins, SC; Hsu, J; Kent, J; Koblan, KS; Loebel, A; Spencer, TJ | 1 |
| Arnold, E; Vandana, P | 1 |
| Davis, M; Farchione, TR; Kim, J; Mosholder, AD | 1 |
| Childress, A; Goldman, R; Hopkins, SC; Hsu, J; Kent, JM; Koblan, KS; Loebel, A; Tsai, J; Wigal, SB | 1 |
| Goldman, R; Hopkins, SC; Jin, F; Koblan, KS; Kollins, SH; Loebel, A; Sarma, K | 1 |
| Hing, J; Hopkins, SC; Koblan, KS; Loebel, A; Passarell, JA; Skende, E; Sunkaraneni, S | 1 |
| Koran, LM; Thienemann, M | 1 |
| Frankenburg, FR; Kando, JC | 1 |
| Findling, RL | 1 |
| Feeney, DJ; Klykylo, WM | 1 |
1 review(s) available for 1-naphthylamine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Dasotraline in ADHD: novel or me too drug?
Topics: 1-Naphthylamine; Attention Deficit Disorder with Hyperactivity; Humans; Neurotransmitter Uptake Inhibitors | 2019 |
6 trial(s) available for 1-naphthylamine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
A Randomized, Placebo-Controlled Laboratory Classroom Study of the Efficacy and Safety of Dasotraline in Children With ADHD.
Topics: 1-Naphthylamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Treatment Outcome | 2022 |
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial.
Topics: 1-Naphthylamine; Adult; Attention Deficit Disorder with Hyperactivity; Humans; Treatment Outcome | 2021 |
Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
Topics: 1-Naphthylamine; Attention Deficit Disorder with Hyperactivity; Child; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Treatment Outcome | 2019 |
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
Topics: 1-Naphthylamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Treatment Outcome | 2020 |
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.
Topics: 1-Naphthylamine; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Do soft signs predict treatment outcome in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adult; Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Obsessive-Compulsive Disorder; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
5 other study(ies) available for 1-naphthylamine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89).
Topics: 1-Naphthylamine; Attention Deficit Disorder with Hyperactivity; Child; Humans | 2019 |
Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
Topics: 1-Naphthylamine; Administration, Oral; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dopamine Uptake Inhibitors; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Models, Biological; Norepinephrine Plasma Membrane Transport Proteins; Randomized Controlled Trials as Topic | 2016 |
Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome.
Topics: 1-Naphthylamine; Adult; Aggression; Attention; Attention Deficit Disorder with Hyperactivity; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Tourette Syndrome | 1994 |
Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.
Topics: 1-Naphthylamine; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Chemotherapy, Adjuvant; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Methylphenidate; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Medication-induced seizures.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Depression; Drug Therapy, Combination; Humans; Male; Methylphenidate; Seizures; Sertraline | 1997 |